-
61
Therapeutic effects of magnesium and vitamin B6 in alleviating the symptoms of restless legs syndrome: a randomized controlled clinical trial
Published 2022-12-01Subjects: Get full text
Article -
62
July 2023 Sleep Case of the Month: Fighting for a Good Night’s Sleep
Published 2023-07-01Subjects: Get full text
Article -
63
Dopaminergic agonists in Parkinson's disease
Published 2014-05-01“…Suspending any DA, especially pramipexole, has been linked to onset of apathy, which may be severe. …”
Get full text
Article -
64
Burning mouth syndrome: clinical description, pathophysiological approach, and a new therapeutic option
Published 2017-05-01“…Each patient had previously received conventional treatments without amelioration. Pramipexol was initiated in doses between 0.36 mg and 1.05 mg per day, resulting in clear improvement of symptoms in all cases, a situation which continues after a 4-year follow up period. …”
Get full text
Article -
65
Parkinsonismo inducido por telmisartán: Reporte de caso
Published 2021-01-01“…PRESENTACIÓN DE CASO: Hombre de 78 años, con antecedentes de enfermedad de Parkinson de dos años de evolución, controlada con levodopa, pramipexol ER y amantadina, ingresa al servicio de urgencias por empeoramiento del parkinsonismo en las dos semanas previas a la consulta. …”
Get full text
Article -
66
Alterações laboratoriais dos medicamentos atuantes no sistema nervoso de uma Relação Municipal de Medicamentos Essenciais do nordeste brasileiro
Published 2024-03-01“…Biperideno, clobazam, hidroxizina, nicotina, pramipexol, piridostigmina, rivastigmina e rasagilina não apresentaram nenhuma alteração in vitro ou in vivo, de acordo com a literatura consultada. …”
Get full text
Article -
67
Alterações laboratoriais dos medicamentos atuantes no sistema nervoso de uma Relação Municipal de Medicamentos Essenciais do nordeste brasileiro
Published 2024-03-01“…Biperideno, clobazam, hidroxizina, nicotina, pramipexol, piridostigmina, rivastigmina e rasagilina não apresentaram nenhuma alteração in vitro ou in vivo, de acordo com a literatura consultada. …”
Get full text
Article -
68
Pharmacological Interaction of Quercetin Derivatives of <i>Tilia americana</i> and Clinical Drugs in Experimental Fibromyalgia
Published 2022-09-01“…To investigate a possible therapeutic alternative for FM-type pain, an aqueous <i>Tilia</i> extract (TE) and its flavonoid fraction (FF) containing rutin and isoquercitrin were evaluated alone and/or combined with clinical drugs (tramadol—TRA and pramipexol—PRA) using the reserpine-induced FM model in rats. …”
Get full text
Article -
69
An experimental medicine investigation of the effects of potential novel antidepressant interventions on emotion and reward related information processing
Published 2020“…The observed effects of the mental practice and of subacute pramipexole treatment deserve further attention and should be interrogated in closer detail in future research.…”
Thesis -
70
Effects of Anti-Parkinsonian Drugs on Verbal Fluency in Patients with Parkinson’s Disease: A Network Meta-Analysis
Published 2022-11-01“…In terms of letter fluency, the ranking of the overall efficacy of included drug regimens was: levodopa, levodopa combined with pramipexole, rotigotine, cabergoline, pramipexole, pergolide, but no drug regimen presented a significant advantage over the others. …”
Get full text
Article -
71
Comparison of the Efficacy of Different Drugs on Non-Motor Symptoms of Parkinson’s Disease: a Network Meta-Analysis
Published 2018-01-01“…Background/Aims: A network meta-analysis is used to compare the efficacy of ropinirole, rasagiline, rotigotine, entacapone, apomorphine, pramipexole, sumanirole, bromocriptine, piribedil and levodopa, with placebo as a control, for non-motor symptoms in Parkinson’s disease (PD). …”
Get full text
Article -
72
Current therapy for Parkinson's disease
Published 2014-10-01“…A novel extended-release formulation of pramipexole is considered separately. Both immediate- and extended-release pramipexole formulations contain the same active ingredient and have the same dopamine-receptor interaction profile, but differ in the tablet release rate of the active ingredient. …”
Get full text
Article -
73
Psychosis and concurrent impulse control disorder in Parkinson's disease: A review based on a case report
Get full text
Article -
74
Comparative efficacy and safety of six non-ergot dopamine-receptor agonists in early Parkinson's disease: a systematic review and network meta-analysis
Published 2023-06-01“…Novel long-acting formulations of NEDAs including pramipexole extended-release (ER), ropinirole prolonged-release (PR), and rotigotine transdermal patch have been developed. …”
Get full text
Article -
75
Linking reward-learning and affect in health and depression
Published 2023“…Combined with the behavioural modelling, this finding indicates that Pramipexole enhances choice accuracy by reducing the decay of estimated values during reward learning.…”
Thesis -
76
DO WE RECOGNIZE RESTLESS GENITAL SYNDROME AND DO WE KNOW HOW TO TREAT IT?
Published 2023-03-01“…In the literature, there are individual cases of patients with the syndrome, who have been administrated treatment with pramipexole. The patient in the present case report has also undergone treatment with pramipexole and has been observed for a period of two years.…”
Get full text
Article -
77
Comparative efficacy and safety of adjunctive drugs to levodopa for fluctuating Parkinson’s disease - network meta-analysis
Published 2023-10-01“…In terms of tolerability, ropinirole (0.954) ranked the highest, followed by pramipexole (0.857), safinamide (0.717), and ropinirole ER (0.708). …”
Get full text
Article -
78
The treatment efficacy of pharmacotherapies for rapid eye movement sleep behavior disorder with polysomnography evaluation: A systematic review and meta-analysis
Published 2022-11-01“…We also found that pramipexole had different effects on idiopathic RBD (iRBD) and secondary RBD (sRBD). …”
Get full text
Article -
79
Impulse control and related behavioral disorders (ICRD) in Idiopathic Parkinson’s Disease treated with different dopamine agonists in Hong Kong: Is any dopamine agonist better?
Published 2024-01-01“…Conclusion: Bromocriptine and probably rotigotine carried a lower ICRD risk compared to pramipexole and ropinirole.…”
Get full text
Article -
80
Profile and frequency of antiparkinsonian drugs adverse reactions: a systematic review and meta-analysis
Published 2021-06-01“…Dizziness was more common with pramipexole and ropinirole than with levodopa (OR=1.82; 95% CI: 1.21–2.74 and OR=1.65; 95% CI: 1.11–2.44 respectively). …”
Get full text
Article